TE_12393
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 173.85 |
| Counts of samples | TCGA_tumor:616; TCGA_normal:1; GTEx:2 |
| TSS | chr5(+):30823612 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_12393.51 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30824046,30824408,30824569,30825749,30825836,30896207,30896279,30947401,30947421 |
| teRNA_12393.52 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30824046,30824408,30824569,30825749,30825836,30828584,30828637,30830325,30830345 |
| teRNA_12393.53 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30823655,30825749,30825836,30896207,30896279,30947401,30947421 |
| teRNA_12393.54 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30823655,30825749,30825836,30896207,30896279,30942057,30942228,30943485,30943564,30947401,30947421 |
| teRNA_12393.55 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30823655,30825749,30825836,30896207,30896279,30943485,30943564,30947401,30947488,30947602,30947622 |
| teRNA_12393.56 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30823655,30825749,30825836,30840754,30842542,30844957,30844977 |
| teRNA_12393.57 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30823655,30825749,30825836,30844957,30845075,30881141,30881161 |
| teRNA_12393.58 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30823655,30825749,30825836,30896207,30896279,30943485,30943505 |
| teRNA_12393.59 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30824046,30825749,30825836,30844957,30844977 |
| teRNA_12393.60 | - | Intergenic | Non-coding | Non-coding | chr5(+):30823613,30824046,30825749,30825836,30840754,30840774 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
